Related Experiment Video
Updated: Jun 17, 2026
05:47
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
The use of computer models in pharmaceutical safety evaluation
1Global Safety Assessment, AstraZeneca R&D, Mölndal, Sweden. scott.boyer@astrazeneca.com
Alternatives to Laboratory Animals : ATLA
|December 19, 2009
Summary
Scientists can better assess drug safety by structuring and analyzing vast datasets using informatics and modeling. This approach ensures objective decision-making and integrates data into experimental design for improved drug discovery outcomes.
Area of Science:
- Computational chemistry and cheminformatics
- Pharmacology and toxicology
- Data science in drug development
Background:
- Increasing data volumes in drug discovery necessitate advanced analytical methods.
- Traditional data analysis risks information exclusion or misinterpretation.
- Informatics and modeling offer objective and transparent data assessment.
Purpose of the Study:
- To review the role of informatics and modeling in drug safety assessment.
- To explore current and future directions in data analysis for drug discovery.
- To highlight the challenges and opportunities in transforming data into actionable information.
Main Methods:
- Structured data analysis using informatics tools.
- Objective data interpretation to inform decision-making.
- Integration of computational models into experimental design processes.
Main Results:
- Informatics and modeling provide transparent and objective data structuring and analysis.
- Models can be incorporated into the experimental design process for enhanced efficiency.
- Addressing the transformation of raw data into useful information is a key challenge.
Conclusions:
- Informatics and modeling are crucial for leveraging big data in drug safety.
- Effective data utilization requires scientific, technical, and cultural advancements.
- Future directions involve further integration of computational approaches in drug discovery.
Related Concept Videos
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...